Sort
82,697 grants matching “vaccine development”
UAB Center for AIDS Research
$1,605,687University Of Alabama At Birmingham · P30 · FY2003 · AI
Colorado AIDS Clinical Trials Unit
$1,605,670Thomas B. Campbell · University Of Colorado Denver · U01 · FY2009 · AI
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
$1,605,646Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
HIV/AIDS Therapeutic and Non-vaccine Prevention Clinical Research
$1,605,095National Institute Of Allergy And Infectious Diseases · Y01 · FY2012 · AI
Rapid Development of Vaccines for Emerging Viruses
$1,604,857Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Evolution & Maintenance of Memory CD8 T Cells
$1,604,499Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2013 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$1,604,376Judith S. Currier · University Of California Los Angeles · UM1 · FY2015 · AI
Vanderbilt HIV Clinical Trials Unit
$1,603,813David W Haas · Vanderbilt University · UM1 · FY2015 · AI
INTEGRATED PRECLINICAL/CLINICAL AIDS VACCINE DEVELOPMENT
$1,603,662University Of Alabama At Birmingham · P01 · FY2000 · AI
Mechanisms programming Protective Immunity from RhCMV-SIV Vaccine and IL-15 actions
$1,603,595Michael J Gale · University Of Minnesota · P01 · FY2025 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,602,982Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
DEVELOPMENT OF SAPONIN DMLT ADJUVANT (SDA)
$1,602,685Elizabeth Norton · Tulane University Of Louisiana · N01 · FY2023 · AI
Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research
$1,602,139Michael K Axthelm · Oregon Health & Science University · U42 · FY2018 · OD
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
$1,601,718Benjamin Jacob Doranz · Integral Molecular · N01 · FY2012 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$1,601,545Scott M Hammer · Columbia University Health Sciences · U01 · FY2009 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Natural History Challenge Study for Influenza
$1,601,464Karen Kotloff · University Of Maryland Baltimore · N01 · FY2019 · AI
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors
$1,600,303Alan Thomas Johnson · Hawaii Biotech, Inc. · R01 · FY2017 · AI
Non-Invasive Plant Virus Particle-Based Anthrax Vaccines
$1,600,155Dow Chemical Company · U01 · FY2005 · AI
Drug Repurposing Screening for Zika Virus Infection
$1,600,138Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Production of an NP-ISS conjugate vaccine to combat pandemic influenza.
$1,600,000Gary A Van Nest · Dynavax Technologies Corporation · U01 · FY2007 · AI
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$1,600,000Mark M Davis · Stanford University · U19 · FY2009 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$1,600,000Jacques F Banchereau · Baylor Research Institute · U19 · FY2009 · AI
EVALUATING NON-AIDS INFECTIOUS DISEASE CONTROL MEASURES
$1,600,000Children'S Hospital Med Ctr (Cincinnati) · N01 · FY2000 · AI
Miami Center for AIDS Research
$1,600,000Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2017 · AI
Multiscale Analysis of Immune Responses
$1,599,752Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI